International Guillain-Barré Syndrome Outcome Study

Conditions

Guillain-Barré Syndrome | Miller Fisher Syndrome

What is the purpose of this trial?

International GBS Outcome Study (IGOS) is a study conducted by the members of the Inflammatory Neuropathy Consortium (INC) and Peripheral Nerve Society (PNS) on disease course and outcome in Guillain-Barré syndrome (GBS).

The IGOS aims to identify clinical and biological determinants and predictors of disease course and outcome in individual patients with Guillain-Barré syndrome, as early as possible after onset of disease.



Participation Guidelines

Age:
N/A - N/A
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Erasmus Medical Center
Dates:
May 2012
Last Updated:
November 26, 2013
Study HIC#:

Clinicaltrials.gov ID: NCT01582763